Current market trends establish a product need. Drug recalls have been steadily increasing since 2014. Products containing undeclared drug ingredients or particulate matter have been the most common reason for recalls since 2009.
Inquest science exclusivity
Today there is not an integrated expert system or relational software database available. Inquest Science has developed a software package that integrates a functional product life cycle approach that will allow companies to review complete product information from raw materials to finished product.
why choose us
Accuracy and assurance
- Chief Executive Officer
Mr. Amato founded InQuest Science in March of 2017. He founded Amega Scientific Corporation in 1999. He grew the company from a start up operation to a world wide industry leader..
- Chief Science Officer
Mr. Cherris has over 40 years of Quality Assurance experience. He is a founding member and Managing Partner of Bridge Associates International. He is an expert in the field of visual inspection..
- Chief Technology Officer
Mr Marino runs a successful software consultancy, BaSys Tech Services. He began his career in the pharmaceutical industry in 1993 building vision and barcode inspection systems..
- Director of Business Operations
Ms. Schwanda was the Director of Business Operations for Amega Scientific Corporation. She was responsible for the groups global business development..
- VP, Product Development
Ms. Chepurny was the Director of Marketing for Amega Scientific Corporation. A marketing executive with over 10 years of experience in creative concept development and design...
- Digital Marketing Manager
Ms. O'Kane is responsible for developing innovative marketing and branding strategies that increase revenue, drive brand awareness, and solidify customer relationships..
- Scientific Advisor
Mr. Aldrich has worked in the pharmaceutical industry for forty years. His passion is the application of materials science methods for the identification of particulate matter..
Mr. Winton is a private equity professional and middle market CFO with more than 12 years of finance, investment banking, and corporate strategy experience..
The vast majority of recalls are injectable drugs. Recalled due to the presence of particulate matter. These particles could be natural growths such as mold, or man made materials, like glass or rubber.